Journal
CANCER SCIENCE
Volume 106, Issue 2, Pages 179-185Publisher
WILEY-BLACKWELL
DOI: 10.1111/cas.12594
Keywords
Autologous stem cell transplantation; immunomodulator drugs; International Staging System; multiple myeloma; proteasome inhibitors
Categories
Funding
- International Myeloma Foundation Japan
- Grants-in-Aid for Scientific Research [15K08644] Funding Source: KAKEN
Ask authors/readers for more resources
We evaluated the clinical significance of prognostic factors including the International Staging System (ISS) and modified European Group for Blood and Marrow Transplantation response criteria in 1650 Japanese patients with multiple myeloma (MM) who underwent upfront single autologous stem cell transplantation (ASCT). We categorized patients into two treatment cohorts: pre-novel agent era (1995-2006) and novel agent era (2008-2011). The combined percentage of pre-ASCT complete response and very good partial response cases (463 of 988, 47%) significantly increased during the novel agent era compared with the pre-novel agent era (164 of 527, 31%; P<0.0001). The 2-year overall survival (OS) rate of 87% during the novel agent era was a significant improvement relative to that of 82% during the pre-novel agent era (P=0.019). Although significant differences in OS were found among ISS stages during the pre-novel agent era, no significant difference was observed between ISS I and II (P=0.107) during the novel agent era. The factors independently associated with a superior OS were female gender (P=0.002), a good performance status (P=0.024), lower ISS (P<0.001), pre-ASCT response at least partial response (P<0.001) and ASCT during the novel agent era (P=0.017). These results indicate that the response rate and OS were significantly improved, and the ISS could not clearly stratify the prognoses of Japanese patients with MM who underwent upfront single ASCT during the novel agent era.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available